News
HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target
20 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Oppenheimer Maintains Outperform on Lumos Pharma, Maintains $16 Price Target
8 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target
8 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Lumos Pharma: Q4 Earnings Insights
7 Mar 24
Earnings
Lumos Pharma Q4 2023 GAAP EPS $(1.170) Misses $(1.150) Estimate, Sales $826.000K Beat $1.750K Estimate
7 Mar 24
Earnings, Earnings Beats, Earnings Misses, News
Earnings Scheduled For March 7, 2024
7 Mar 24
Earnings
Earnings Preview: Lumos Pharma
6 Mar 24
Earnings
Press releases
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
20 Mar 24
Biotech, News, Health Care, Legal, Press Releases, General
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
7 Mar 24
Biotech, Earnings, Health Care, Press Releases, General
Lumos Pharma to Participate in Oppenheimer's 34th Annual Healthcare Life Sciences Conference
5 Feb 24
Biotech, News, Health Care, Press Releases, General